The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower150: Exploratory analysis of brain metastases development.
 
Federico Cappuzzo
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; MSD Oncology; pfizer; Roche/Genentech; Takeda
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Lilly
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)
 
Tony S. K. Mok
Employment - The Chinese University of Hong Kong
Leadership - AstraZeneca; Hutchison MediPharma; Sanomics Limited
Stock and Other Ownership Interests - Hutchison MediPharma; Sanomics Limited
Honoraria - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Fishawack Facilitate; Hutchison MediPharma; Ignyta; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Takeda; Vertex
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Cirina; Clovis Oncology; geneDecode; Hutchison MediPharma; Ignyta; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst); Xcovery (Inst)
 
Robert M. Jotte
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Gene Grant Finley
Stock and Other Ownership Interests - Proteostasis Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Roche; Roche
Research Funding - AstraZeneca (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Joachim Aerts
Stock and Other Ownership Interests - amphera
Consulting or Advisory Role - Amphera; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Roche; Takeda
Patents, Royalties, Other Intellectual Property - cdendritic cel based immunotherapy (Inst); combination immunotherapy (Inst); proteomics in nsclc (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Howard West
Honoraria - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Merck; Pfizer; PharmaMar; Spectrum Pharmaceuticals; Takeda
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Merck; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Genentech/Roche; Lilly; Takeda
 
Makoto Nishio
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AbbVie; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Teijin Pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Liza C Villaruz
Consulting or Advisory Role - Achilles Therapeutics
Research Funding - AstraZeneca (Inst); Celgene (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Rain Therapeutics (Inst)
 
Shelly Coleman
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Anthony Lee
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Hans Kristian Vollan
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Wei Yu
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
 
Roxana Ioana Sufan
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Ilze Bara
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Fabrice Barlesi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Ignyta (Inst); Innate Pharma (Inst); Ipsen (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)